In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory velocity becomes a binding constraint Read more at The Business ...

Johnson & Johnson’s Abiomed has sent an urgent medical device correction about a malfunction risk linked to 22 reports of ...

Leede Financial analyst Douglas Loe has initiated coverage of Satellos Biosciences with a “Speculative Buy” rating and a ...

Eli Lilly and Company (NYSE:LLY) reported fourth-quarter financial results on Wednesday. The transcript from the earnings call has been provided below.

Life expectancy hits all-time high at 79 years in 2024 as U.S. drug overdose deaths decline by 26.2%, reports CDC data.

Tuesday afternoon, the House of Representatives voted in favor of a spending bill that includes major pharmacy benefit manager (PBM) reforms aimed at increasing price transparency for consumers and ...

MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2025. Second quarter revenue was $295.9 ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...

At 31 October 2025, net liabilities of the Group amounted to £8.4 million (30 April 2025: £3.8 million) and it held cash of £8.6 million (30 April 2025: £16.9 million). R&D tax credits of £3.0 million ...

Focused Execution Drives Strong Full-Year 2025 EPS Performance. Enters 2026 with Clear Strategic Priorities and Growing Late-Stage Pipeline. Advanced 11 Key Pivotal Study Starts i ...

Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...

Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review ...